JP2014533733A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014533733A5 JP2014533733A5 JP2014543607A JP2014543607A JP2014533733A5 JP 2014533733 A5 JP2014533733 A5 JP 2014533733A5 JP 2014543607 A JP2014543607 A JP 2014543607A JP 2014543607 A JP2014543607 A JP 2014543607A JP 2014533733 A5 JP2014533733 A5 JP 2014533733A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- unit dosage
- dosage form
- item
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161564500P | 2011-11-29 | 2011-11-29 | |
| US61/564,500 | 2011-11-29 | ||
| USPCT/US2012/055621 | 2012-09-14 | ||
| PCT/US2012/055621 WO2013040492A2 (en) | 2011-09-16 | 2012-09-14 | Methods for treating hcv |
| US201261707459P | 2012-09-28 | 2012-09-28 | |
| US61/707,459 | 2012-09-28 | ||
| US13/661,509 | 2012-10-26 | ||
| US13/661,509 US20130109647A1 (en) | 2011-10-31 | 2012-10-26 | Methods and compositions for treating hepatitis c virus |
| PCT/US2012/066605 WO2013082003A1 (en) | 2011-11-29 | 2012-11-27 | Compositions and methods for treating hepatitis c virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016007633A Division JP2016053096A (ja) | 2011-11-29 | 2016-01-19 | Ｃ型肝炎ウイルスを処置するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014533733A JP2014533733A (ja) | 2014-12-15 |
| JP2014533733A5 true JP2014533733A5 (cg-RX-API-DMAC7.html) | 2015-04-30 |
| JP5899327B2 JP5899327B2 (ja) | 2016-04-06 |
Family
ID=56291296
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543607A Active JP5899327B2 (ja) | 2011-11-29 | 2012-11-27 | Ｃ型肝炎ウイルスを処置するための組成物および方法 |
| JP2016007633A Withdrawn JP2016053096A (ja) | 2011-11-29 | 2016-01-19 | Ｃ型肝炎ウイルスを処置するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016007633A Withdrawn JP2016053096A (ja) | 2011-11-29 | 2016-01-19 | Ｃ型肝炎ウイルスを処置するための組成物および方法 |
Country Status (21)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2840242C (en) | 2011-09-16 | 2019-03-26 | Gilead Sciences, Inc. | Methods for treating hcv |
| EP3650013A1 (en) | 2013-01-31 | 2020-05-13 | Gilead Pharmasset LLC | Combination formulation of two antiviral compounds |
| WO2015132321A1 (en) * | 2014-03-05 | 2015-09-11 | Galenicum Health S.L. | Stable pharmaceutical compositions of sofosbuvir |
| WO2015189386A1 (en) * | 2014-06-13 | 2015-12-17 | Teva Pharmaceuticals International Gmbh | Composition with a high drug load of sofosbuvir |
| US20170112867A1 (en) * | 2014-06-23 | 2017-04-27 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Pharmaceutical combinations of sofosbuvir and ribavirin |
| WO2015197549A1 (en) * | 2014-06-23 | 2015-12-30 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A novel pharmaceutical composition of sofosbuvir and ribavirin |
| EP2959891A1 (en) * | 2014-06-23 | 2015-12-30 | Sanovel Ilac Sanayi ve Ticaret A.S. | Modified release pharmaceutical compositions of sofosbuvir and ribavirin |
| CN105267232A (zh) * | 2014-06-30 | 2016-01-27 | 康普药业股份有限公司 | 一种用于治疗丙型肝炎的药物制剂及其制备方法 |
| WO2016035006A1 (en) * | 2014-09-01 | 2016-03-10 | Dr. Reddy’S Laboratories Limited | Novel nucleotide analogs, process for the preparation of sofosbuvir and its analogs, novel forms of sofosbuvir and solid dispersion of sofosbuvir |
| WO2016055576A1 (en) * | 2014-10-08 | 2016-04-14 | Sandoz Ag | High drug load tablets comprising sofosbuvir |
| CN104546783A (zh) * | 2014-12-12 | 2015-04-29 | 安徽一灵药业有限公司 | 一种索非布韦薄膜包衣片制剂及其制备方法 |
| CN104622836B (zh) * | 2014-12-23 | 2020-02-21 | 浙江华海药业股份有限公司 | 索非布韦包衣片剂及其制备方法 |
| CN107427529A (zh) | 2014-12-26 | 2017-12-01 | 埃莫里大学 | N4‑羟基胞苷和衍生物及与其相关的抗病毒用途 |
| CN104586802B (zh) * | 2015-02-02 | 2018-01-16 | 长春海悦药业股份有限公司 | 一种含有索菲布韦的药物组合物 |
| WO2016156330A1 (en) * | 2015-03-30 | 2016-10-06 | Ratiopharm Gmbh | Solid pharmaceutical composition comprising amorphous sofosbuvir and a phospholipid |
| CN104840964B (zh) * | 2015-05-07 | 2018-01-16 | 南京正大天晴制药有限公司 | 一种稳定的索氟布韦药物组合物及其制备方法 |
| CZ2015443A3 (cs) | 2015-06-26 | 2017-01-04 | Zentiva, K.S. | Farmaceutická formulace sofosbuviru |
| CN104906062B (zh) * | 2015-06-30 | 2018-05-25 | 浙江天顺生物科技有限公司 | 一种索非布韦的片剂及其制备方法 |
| BR102017011025A2 (pt) | 2016-06-02 | 2017-12-19 | Gilead Pharmasset Llc | Formulation of combination of three antiviral compounds |
| AU2017314148A1 (en) | 2016-08-19 | 2019-02-28 | Sandoz Ag | Sofosbuvir derivatives for the treatment of Hepatitis C |
| CZ2016553A3 (cs) | 2016-09-09 | 2018-03-21 | Zentiva, K.S. | Pevná farmaceutická dávková forma obsahující sofosbuvir |
| CN106667936B (zh) * | 2016-12-31 | 2021-02-05 | 江苏科本药业有限公司 | 一种索非布韦片剂及其制备方法 |
| CN107041873B (zh) * | 2017-02-17 | 2020-02-28 | 杭州青玥医药科技有限公司 | 索氟布韦包衣片剂的制备方法 |
| CN106880642B (zh) * | 2017-02-17 | 2019-08-06 | 杭州青玥医药科技有限公司 | 索氟布韦药物组合物及其制备方法 |
| ES2995458T3 (en) | 2017-12-07 | 2025-02-10 | Univ Emory | N4-hydroxycytidine derivative and anti-viral uses related thereto |
| KR20200043618A (ko) | 2018-10-18 | 2020-04-28 | 주식회사유한양행 | 아미노피리미딘 유도체 또는 이의 염을 포함하는 경구투여용 약학 조성물 |
| CN110604726B (zh) * | 2019-07-19 | 2022-06-07 | 株洲千金药业股份有限公司 | 一种索非布韦组合物及其应用 |
| CN111072742B (zh) * | 2019-12-23 | 2022-12-02 | 南京正大天晴制药有限公司 | 一种治疗丙肝药物的新晶型及其组合物 |
| CN111973566A (zh) * | 2020-07-23 | 2020-11-24 | 石药集团中奇制药技术（石家庄）有限公司 | 一种索磷布韦片 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| IL154306A0 (en) * | 2003-02-05 | 2003-09-17 | Rimonyx Pharmaceuticals Ltd | Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof |
| US7816326B2 (en) * | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
| WO2008106130A2 (en) * | 2007-02-26 | 2008-09-04 | Achillion Pharmaceuticals, Inc. | Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| NZ583825A (en) | 2007-09-14 | 2012-06-29 | Schering Corp | Method of treating hepatitis C patients comprising an HCV protease inhibitor, an antiviral compound and an interferon |
| DE102007052070A1 (de) * | 2007-10-30 | 2009-05-07 | Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg | Candesartancilexetil |
| DE102008057284A1 (de) * | 2008-11-14 | 2010-05-20 | Ratiopharm Gmbh | Tabletten enthaltend Lenalidomid und Adhäsionsverstärker |
| WO2010059937A1 (en) * | 2008-11-20 | 2010-05-27 | Achillion Pharmaceuticals, Inc. | Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus |
| DE102009015702A1 (de) * | 2009-03-31 | 2010-10-07 | Ratiopharm Gmbh | Tabletten enthaltend Dapoxetin und Trockenverarbeitungsverfahren zu deren Herstellung |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| WO2011009961A1 (en) * | 2009-07-24 | 2011-01-27 | Virologik Gmbh | Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis |
| LT2609923T (lt) * | 2010-03-31 | 2017-09-11 | Gilead Pharmasset Llc | (s)-izopropilo 2-(((s)-(perfluorfenoksi)(fenoksi)fosforil)amino)-propanoato kristalinimo būdas |
| US20120107278A1 (en) | 2010-10-29 | 2012-05-03 | Pharmasset, Inc. | Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype |
-
2012
- 2012-11-27 EP EP12795307.3A patent/EP2785340B1/en active Active
- 2012-11-27 PE PE2014000749A patent/PE20141296A1/es active IP Right Grant
- 2012-11-27 MD MDA20140058A patent/MD4430C1/ro active IP Right Grant
- 2012-11-27 CA CA2856529A patent/CA2856529C/en active Active
- 2012-11-27 KR KR1020147016699A patent/KR101560994B1/ko active Active
- 2012-11-27 MX MX2014006373A patent/MX2014006373A/es unknown
- 2012-11-27 BR BR112014012739A patent/BR112014012739A8/pt not_active Application Discontinuation
- 2012-11-27 AU AU2012346217A patent/AU2012346217B2/en active Active
- 2012-11-27 EP EP20176183.0A patent/EP3777867A1/en not_active Withdrawn
- 2012-11-27 EA EA201490903A patent/EA027296B1/ru unknown
- 2012-11-27 ES ES12795307T patent/ES2817886T3/es active Active
- 2012-11-27 JP JP2014543607A patent/JP5899327B2/ja active Active
- 2012-11-27 SG SG11201402609RA patent/SG11201402609RA/en unknown
- 2012-11-27 WO PCT/US2012/066605 patent/WO2013082003A1/en not_active Ceased
- 2012-11-27 CN CN201280058114.0A patent/CN104039319B/zh active Active
- 2012-11-28 TW TW101144495A patent/TWI566773B/zh active
- 2012-11-28 UY UY0001034474A patent/UY34474A/es active IP Right Grant
- 2012-11-29 AR ARP120104483A patent/AR089578A1/es not_active Application Discontinuation
-
2014
- 2014-05-21 PH PH12014501133A patent/PH12014501133A1/en unknown
- 2014-05-30 ZA ZA2014/04061A patent/ZA201404061B/en unknown
- 2014-06-05 CO CO14121393A patent/CO6970603A2/es not_active Application Discontinuation
- 2014-06-18 EC ECIEPI20145678A patent/ECSP14005678A/es unknown
-
2016
- 2016-01-19 JP JP2016007633A patent/JP2016053096A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014533733A5 (cg-RX-API-DMAC7.html) | ||
| FI3804715T3 (fi) | Farmaseuttinen yhdistelmä, koostumus ja yhdistelmävalmiste, joka käsittää glukokinaasin aktivaattorin ja dpp-iv:n estäjän ja niiden valmistusmenetelmä ja käyttö | |
| RU2016122609A (ru) | Составы соединений азаиндола | |
| WO2009043448A3 (en) | Neuromedin u-25 and neuromedin s as therapeutic agents | |
| FI3265084T3 (fi) | Brutonin tyrosiinikinaasin estäjän lääkeformulaatioita | |
| RU2015110699A (ru) | Фармацевтическая антиретровирусная композиция | |
| JP2015524444A5 (cg-RX-API-DMAC7.html) | ||
| WO2009043504A3 (en) | Use of apelin-36 and optionally beta-melanotropin as therapeutic agents, eg for treating aids or alzheimer | |
| WO2009039980A3 (en) | Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection | |
| JP2014515373A5 (cg-RX-API-DMAC7.html) | ||
| RU2004129324A (ru) | Применения бисфосфоновых кислот для лечения и профилактики остеопороза | |
| WO2009046832A3 (en) | Short peptides used in medicine | |
| JP7383715B2 (ja) | アファビシン製剤、その作製方法及びその使用 | |
| WO2009033794A3 (en) | Use of endothelin-1, optionally in combination with obestatin, as a therapeutic agent | |
| MX2009003317A (es) | Tabletas pediatricas de capecitabina. | |
| RU2013154355A (ru) | Способ лечения мезотелиомы ингибитором рi3к | |
| RU2008119410A (ru) | Диспергируемые таблетки, включающие деферасирокс | |
| US20200179291A1 (en) | Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine | |
| WO2009043479A3 (en) | Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections | |
| JP2020500168A5 (cg-RX-API-DMAC7.html) | ||
| JP6088429B2 (ja) | 関節リウマチなどの自己免疫疾患の治療の改善方法 | |
| ES2286716T3 (es) | Composicion farmaceutica de liberacion controlada y proceso para preparar la misma. | |
| EP3801532B1 (en) | Formulations of raltegravir | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
| EP3496719B1 (en) | A multi-class anti-retroviral composition |